These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37373067)

  • 21. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of protein phosphatase 2A activity alters androgen-independent growth of prostate cancer cells: therapeutic implications.
    Bhardwaj A; Singh S; Srivastava SK; Honkanen RE; Reed E; Singh AP
    Mol Cancer Ther; 2011 May; 10(5):720-31. PubMed ID: 21393425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Abhydrolase domain containing 2, an androgen target gene, promotes prostate cancer cell proliferation and migration.
    Obinata D; Takada S; Takayama K; Urano T; Ito A; Ashikari D; Fujiwara K; Yamada Y; Murata T; Kumagai J; Fujimura T; Ikeda K; Horie-Inoue K; Homma Y; Takahashi S; Inoue S
    Eur J Cancer; 2016 Apr; 57():39-49. PubMed ID: 26854828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc.
    Chuu CP; Kokontis JM; Hiipakka RA; Fukuchi J; Lin HP; Lin CY; Huo C; Su LC; Liao S
    Cancer Sci; 2011 Nov; 102(11):2022-8. PubMed ID: 21781227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progression.
    Jin F; Fondell JD
    Nucleic Acids Res; 2009 Aug; 37(14):4826-38. PubMed ID: 19520769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2.
    Zhang Y; Wang LN; Lin YN; Xing YX; Shi Y; Zhao J; Chen WW; Han B
    Asian J Androl; 2018; 20(5):511-517. PubMed ID: 29956684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor knockdown enhances prostate cancer chemosensitivity by down-regulating FEN1 through the ERK/ELK1 signalling pathway.
    Xie W; Li S; Guo H; Zhang J; Tu M; Wang R; Lin B; Wu Y; Wang X
    Cancer Med; 2023 Jul; 12(14):15317-15336. PubMed ID: 37326412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
    Dulinska-Litewka J; McCubrey JA; Laidler P
    Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibition of androgen-responsive prostate cancer cells with brefeldin A targeting cell cycle and androgen receptor.
    Rajamahanty S; Alonzo C; Aynehchi S; Choudhury M; Konno S
    J Biomed Sci; 2010 Jan; 17(1):5. PubMed ID: 20102617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxiredoxin 2 in the nucleus and cytoplasm distinctly regulates androgen receptor activity in prostate cancer cells.
    Shiota M; Yokomizo A; Kashiwagi E; Takeuchi A; Fujimoto N; Uchiumi T; Naito S
    Free Radic Biol Med; 2011 Jul; 51(1):78-87. PubMed ID: 21539911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Androgen-regulated processing of the oncomir miR-27a, which targets Prohibitin in prostate cancer.
    Fletcher CE; Dart DA; Sita-Lumsden A; Cheng H; Rennie PS; Bevan CL
    Hum Mol Genet; 2012 Jul; 21(14):3112-27. PubMed ID: 22505583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen-dependent regulation of Her-2/neu in prostate cancer cells.
    Berger R; Lin DI; Nieto M; Sicinska E; Garraway LA; Adams H; Signoretti S; Hahn WC; Loda M
    Cancer Res; 2006 Jun; 66(11):5723-8. PubMed ID: 16740710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of a novel androgen receptor target gene, the cyclin B1 gene, through androgen-dependent E2F family member switching.
    Li Y; Zhang DY; Ren Q; Ye F; Zhao X; Daniels G; Wu X; Dynlacht B; Lee P
    Mol Cell Biol; 2012 Jul; 32(13):2454-66. PubMed ID: 22508987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression.
    Karacosta LG; Foster BA; Azabdaftari G; Feliciano DM; Edelman AM
    J Biol Chem; 2012 Jul; 287(29):24832-43. PubMed ID: 22654108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. AZGP1 is androgen responsive and involved in AR-induced prostate cancer cell proliferation and metastasis.
    Cao R; Ke M; Wu Q; Tian Q; Liu L; Dai Z; Lu S; Liu P
    J Cell Physiol; 2019 Aug; 234(10):17444-17458. PubMed ID: 30820960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.
    Shiota M; Yokomizo A; Tada Y; Inokuchi J; Tatsugami K; Kuroiwa K; Uchiumi T; Fujimoto N; Seki N; Naito S
    Mol Endocrinol; 2010 Jan; 24(1):114-27. PubMed ID: 19884383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.